Citadel Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $222M | Sell |
241,714
-458,045
| -65% | -$464M | 0.04% | 410 |
|
|
2025
Q4 | $752M | Sell |
699,759
-453,059
| -39% | -$433M | 0.11% | 112 |
|
|
2025
Q3 | $880M | Buy |
1,152,818
+299,566
| +35% | +$223M | 0.13% | 90 |
|
|
2025
Q2 | $665M | Buy |
853,252
+375,471
| +79% | +$292M | 0.12% | 111 |
|
|
2025
Q1 | $395M | Sell |
477,781
-133,494
| -22% | -$111M | 0.07% | 180 |
|
|
2024
Q4 | $472M | Buy |
611,275
+396,093
| +184% | +$328M | 0.08% | 160 |
|
|
2024
Q3 | $191M | Sell |
215,182
-285,653
| -57% | -$257M | 0.04% | 378 |
|
|
2024
Q2 | $453M | Buy |
500,835
+23,722
| +5% | +$19M | 0.09% | 138 |
|
|
2024
Q1 | $371M | Sell |
477,113
-798,919
| -63% | -$569M | 0.07% | 190 |
|
|
2023
Q4 | $744M | Buy |
1,276,032
+516,239
| +68% | +$301M | 0.15% | 67 |
|
|
2023
Q3 | $408M | Buy |
759,793
+213,671
| +39% | +$110M | 0.09% | 130 |
|
|
2023
Q2 | $256M | Buy |
546,122
+296,101
| +118% | +$124M | 0.05% | 237 |
|
|
2023
Q1 | $85.9M | Buy |
250,021
+73,307
| +41% | +$24.7M | 0.02% | 707 |
|
|
2022
Q4 | $64.6M | Sell |
176,714
-806,571
| -82% | -$286M | 0.02% | 932 |
|
|
2022
Q3 | $318M | Sell |
983,285
-181,800
| -16% | -$57.6M | 0.07% | 177 |
|
|
2022
Q2 | $378M | Buy |
1,165,085
+1,123,361
| +2,692% | +$337M | 0.1% | 127 |
|
|
2022
Q1 | $11.9M | Sell |
41,724
-92,520
| -69% | -$23.8M | ﹤0.01% | 2690 |
|
|
2021
Q4 | $37.1M | Buy |
134,244
+47,019
| +54% | +$11.9M | 0.01% | 1422 |
|
|
2021
Q3 | $20.2M | Sell |
87,225
-401,002
| -82% | -$99M | ﹤0.01% | 1973 |
|
|
2021
Q2 | $112M | Buy |
488,227
+376,546
| +337% | +$75.6M | 0.03% | 607 |
|
|
2021
Q1 | $20.9M | Sell |
111,681
-2,013,741
| -95% | -$394M | 0.01% | 1913 |
|
|
2020
Q4 | $359M | Buy |
2,125,422
+1,554,906
| +273% | +$232M | 0.09% | 127 |
|
|
2020
Q3 | $84.4M | Sell |
570,516
-711,139
| -55% | -$110M | 0.02% | 558 |
|
|
2020
Q2 | $210M | Buy |
1,281,655
+1,270,416
| +11,304% | +$195M | 0.08% | 166 |
|
|
2020
Q1 | $1.56M | Sell |
11,239
-100,689
| -90% | -$13.8M | ﹤0.01% | 4549 |
|
|
2019
Q4 | $14.7M | Sell |
111,928
-223,548
| -67% | -$25.9M | 0.01% | 1792 |
|
|
2019
Q3 | $37.5M | Buy |
335,476
+34,070
| +11% | +$3.79M | 0.02% | 960 |
|
|
2019
Q2 | $33.4M | Sell |
301,406
-3,372,002
| -92% | -$397M | 0.02% | 991 |
|
|
2019
Q1 | $477M | Buy |
3,673,408
+3,307,234
| +903% | +$402M | 0.24% | 37 |
|
|
2018
Q4 | $42.4M | Buy |
366,174
+46,164
| +14% | +$5.16M | 0.02% | 707 |
|
|
2018
Q3 | $34.3M | Sell |
320,010
-16,231
| -5% | -$1.62M | 0.02% | 986 |
|
|
2018
Q2 | $28.7M | Buy |
336,241
+172,940
| +106% | +$14.2M | 0.01% | 1027 |
|
|
2018
Q1 | $12.6M | Buy |
163,301
+133,113
| +441% | +$10.7M | 0.01% | 1515 |
|
|
2017
Q4 | $2.55M | Sell |
30,188
-87,004
| -74% | -$7.4M | ﹤0.01% | 3300 |
|
|
2017
Q3 | $10M | Sell |
117,192
-798,906
| -87% | -$65.5M | 0.01% | 1601 |
|
|
2017
Q2 | $75.4M | Sell |
916,098
-2,662,920
| -74% | -$217M | 0.06% | 325 |
|
|
2017
Q1 | $301M | Buy |
3,579,018
+3,440,064
| +2,476% | +$276M | 0.28% | 36 |
|
|
2016
Q4 | $10.2M | Sell |
138,954
-417,614
| -75% | -$31.1M | 0.01% | 1344 |
|
|
2016
Q3 | $44.7M | Sell |
556,568
-1,013,313
| -65% | -$81.1M | 0.04% | 440 |
|
|
2016
Q2 | $124M | Buy |
1,569,881
+398,634
| +34% | +$30M | 0.14% | 106 |
|
|
2016
Q1 | $84.3M | Sell |
1,171,247
-548,888
| -32% | -$41.5M | 0.11% | 159 |
|
|
2015
Q4 | $145M | Sell |
1,720,135
-2,694,303
| -61% | -$224M | 0.16% | 115 |
|
|
2015
Q3 | $369M | Buy |
4,414,438
+2,869,107
| +186% | +$242M | 0.35% | 26 |
|
|
2015
Q2 | $129M | Buy |
1,545,331
+505,941
| +49% | +$38.6M | 0.11% | 179 |
|
|
2015
Q1 | $75.5M | Sell |
1,039,390
-75,396
| -7% | -$5.37M | 0.07% | 313 |
|
|
2014
Q4 | $76.9M | Buy |
1,114,786
+1,071,150
| +2,455% | +$72.3M | 0.08% | 283 |
|
|
2014
Q3 | $2.83M | Sell |
43,636
-344,948
| -89% | -$21.8M | ﹤0.01% | 2505 |
|
|
2014
Q2 | $24.2M | Buy |
388,584
+161,927
| +71% | +$9.66M | 0.03% | 705 |
|
|
2014
Q1 | $13.3M | Buy |
226,657
+174,495
| +335% | +$9.74M | 0.02% | 1092 |
|
|
2013
Q4 | $2.66M | Sell |
52,162
-1,723,296
| -97% | -$86.3M | ﹤0.01% | 2251 |
|
|
2013
Q3 | $89.4M | Buy |
1,775,458
+1,560,883
| +727% | +$81.7M | 0.14% | 135 |
|
|
2013
Q2 | $10.5M | Buy |
+214,575
| New | +$11.7M | 0.02% | 1035 |
|
Other funds holding LLY
VCM
VPM
Citadel Advisors's LLY Position: Q1 2026 in Review
Citadel Advisors reduced its Eli Lilly (LLY) stake by 65% in Q1 2026, selling an estimated $464M and leaving 241,714 shares worth $222M. The position accounts for 0.04% of the portfolio, ranked #410.
Citadel Advisors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $880M in Q3 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Citadel Advisors held 241,714 shares of Eli Lilly worth $222M as of Q1 2026.
- Citadel Advisors sold 458,045 Eli Lilly shares in Q1 2026, an estimated $464M.
- Eli Lilly made up 0.04% of Citadel Advisors's portfolio in Q1 2026, its #410 holding.
- Citadel Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's Eli Lilly position peaked at $880M in Q3 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.